Millendo is working to ease the burden of patients with severe endocrine diseases
Millendo is leveraging novel biological insights to advance a portfolio of endocrine therapeutics
Millendo is restoring hormonal balance to patients with endocrine diseases
March 14, 2019Millendo Therapeutics Announces ENDO 2019 Presentations on Livoletide for Prader-Willi Syndrome and Nevanimibe for Classic Congenital Adrenal Hyperplasia
March 4, 2019Millendo Therapeutics, Inc. to Present at the Cowen and Company 39th Annual Healthcare Conference and the Oppenheimer 29th Annual Healthcare Conference
